poisar

Stocks · News reference

Mizuho Lowers Price Target on Corbus Pharmaceuticals to $23

Fiscal.ai

Mizuho Securities analyst Graig Suvannavejh lowered the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $23.00 from $24.00 while maintaining an Outperform rating.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading